Cell and gene therapies offer promise, but face market access challenges – The Pharma Letter
The Pharma Letter |
Cell and gene therapies offer promise, but face market access challenges
The Pharma Letter In light of the progress and potential of cell and gene therapies, Amy Grogg, senior vice president of strategy and communication at US drug wholesale company AmerisourceBergen (NYSE: ABC), considers the strategies needed to overcome challenges … |
